Status:
RECRUITING
CivaDerm(TM) Surface Therapy Pilot Study
Lead Sponsor:
CivaTech Oncology
Conditions:
Basal Cell Carcinoma
Squamous Cell Carcinoma of the Skin
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This is a pilot study to determine the usefulness of new brachytherapy device that utilizes active components (palladium-103) of standard devices in a novel configuration, which may benefit basal cell...
Eligibility Criteria
Inclusion
- subject signed informed consent
- Confirmed superficial or nodular basal cell or squamous cell carcinoma
- Biopsy proven on chest, stomach, back, arms, legs, feet (trunk and extremities)
- \>5 mm of residual tumor
- tumors \< 3 cm
- Capable of complying with Patient Release Instructions
Exclusion
- Is unable or unwilling to comply with the protocol requirements
- Pregnant or breast feeding
- Metastases
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04480645
Start Date
May 1 2024
End Date
April 30 2026
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CivaDerm Oncology PLLC
Morrisville, North Carolina, United States, 27560